Literature DB >> 3895254

Cardiovascular effects of single doses of the antidepressants amitriptyline and lofepramine in healthy subjects.

H Stern, J Konetschny, L Herrmann, U Säwe, G G Belz.   

Abstract

In a placebo-controlled double blind study, single oral doses of lofepramine (140 mg and 210 mg) and amitriptyline (100 mg and 150 mg) were given to 5 healthy volunteers. Heart rate, blood pressure, systolic time intervals, and electrical impedance cardiogram were recorded in supine and upright position for 8 hours after drug administration. In addition, plasma drug concentrations were measured simultaneously. Amitriptyline caused a more pronounced increase in heart rate, especially under orthostatic stress, than did lofepramine. Both drugs reduced total peripheral resistance; amitriptyline's effect was greater. A rise in blood pressure (supine position) and shortening of the electromechanical systole under lofepramine indicated an improvement of cardiac performance. In contrast amitriptyline, particularly, in the upright position, lowered blood pressure and lengthened electromechanical systole. Since both drugs have a comparable antidepressant activity, lofepramine is suggested to induce fewer untoward cardiovascular reactions than amitriptyline.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895254     DOI: 10.1055/s-2007-1017380

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  8 in total

Review 1.  Systolic time intervals in clinical pharmacology.

Authors:  Q Li; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  Antidepressants in suicide: differences in fatality and drug utilisation.

Authors:  J Malmvik; C G Löwenhielm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 3.  Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.

Authors:  C Sánchez; J Hyttel
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

4.  Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects.

Authors:  C Strömberg; A Suokas; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  A double-blind comparison of the pharmacodynamic effects of single doses of lofepramine, amitriptyline and placebo in elderly subjects.

Authors:  K Ghose; E Sedman
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  The effect of low dose lofepramine in depressed elderly patients in general medical wards.

Authors:  R S Tan; R J Barlow; C Abel; S Reddy; A J Palmer; A E Fletcher; C G Nicholl; B M Pitt; C J Bulpitt
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

Review 7.  Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  S G Lancaster; J P Gonzalez
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

8.  Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals.

Authors:  Zofia Tylutki; Aleksander Mendyk; Sebastian Polak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-06-25       Impact factor: 2.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.